Related Experiment Video
Updated: Dec 25, 2025
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.5K
Palliative Care for Dementia: 2020 Update.
Jaffrey Hashimie1, Susan K Schultz1, Jonathan T Stewart1
1Psychiatry Service (116A), James A Haley VA Hospital, University of South Florida College of Medicine, 13000 Bruce B Downs Boulevard, Tampa, FL 33612, USA.
Clinics in Geriatric Medicine
|March 31, 2020
Summary
Psychiatry is essential for dementia care, especially for managing neuropsychiatric symptoms and supporting families. Integrating psychiatric services into palliative and hospice care improves end-of-life patient support and advance care planning.
Area of Science:
- Geriatric Psychiatry
- Neuroscience
- Palliative Care Medicine
Background:
- Neuropsychiatric symptoms complicate dementia management.
- Longitudinal psychiatric care is vital for patients and family support.
- Continuity of care is crucial, especially at end-of-life.
Purpose of the Study:
- To highlight the importance of psychiatric involvement in dementia care.
- To explore the integration of psychiatry into palliative and hospice services.
- To identify challenges and opportunities in end-of-life dementia care.
Main Methods:
- Literature review on psychiatric care in dementia.
- Analysis of challenges in palliative and hospice settings.
- Discussion of future research directions.
Main Results:
- Psychiatric care is essential for managing neuropsychiatric symptoms in dementia.
- Integration with palliative and hospice care offers growth opportunities.
- Key challenges include prognostic communication and symptom management (pain, nutrition).
Conclusions:
- Psychiatry plays a critical role in comprehensive dementia care.
- Enhanced collaboration in palliative and hospice settings is needed.
- Further research is required to develop new guidelines for end-of-life dementia care.
Related Concept Videos
01:30Dementia
456
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
456
01:25Continuing Care
1.8K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
01:22Alzheimer's Disease: Treatment
697
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
697
01:26Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
01:24Parkinson's Disease: Treatment
867
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
867
01:15Parkinson's Disease: Overview
1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K